Diagnosis, management, and treatment of hepatitis C: an update - Wikidata - wikimedia - TriplyDB

Diagnosis, management, and treatment of hepatitis C: an update

Diagnosis, management, and treatment of hepatitis C: an update

http://www.wikidata.org/entity/Q29619682

about

Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis Treatment of hepatitis C in children: a systematic review Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutations Liver involvement in subjects with rheumatic disease Hepatitis C genotype 6: A concise review and response-guided therapy proposal New perspectives in occult hepatitis C virus infection Chronic hepatitis C in the state prison system: insights into the problems and possible solutions Aminoadamantanes versus other antiviral drugs for chronic hepatitis C Aminoadamantanes for chronic hepatitis C Aminoadamantanes versus other antiviral drugs for chronic hepatitis C Nitazoxanide for chronic hepatitis C Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients Aminoadamantanes for chronic hepatitis C Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus Nitazoxanide for chronic hepatitis C virus infection Interferon alpha for chronic hepatitis D Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks for patients with chronic hepatitis C virus genotype 1 infection having shown slow antiviral response Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C Role for TBC1D20 and Rab1 in hepatitis C virus replication via interaction with lipid droplet-bound nonstructural protein 5A Hepatitis C virus protease inhibitor-resistance mutations: our experience and review Antiviral drugs for viruses other than human immunodeficiency virus Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective KASL clinical practice guidelines: management of hepatitis C Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1 Entry inhibitors: New advances in HCV treatment Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage Hepatitis C genotype 4: The past, present, and future Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection Treatment of Hepatitis C Virus Infection in Children Less than 12 Years of Age in Developing Countries Hepatitis B and Hepatitis C Reactivation in the Biologic Era Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance

P2860

Q21132564-1976A676-A5D8-45CD-BFA9-62EE390A0B2E Q21136318-7683A89F-14A1-4E66-A990-04C32EB4C397 Q21560973-E33757D8-33CE-4D29-863E-28E55D7A369C Q22000839-8AF1A391-9AD4-4FCB-9D57-3CFAE3C9198C Q22305417-BBB5BE5E-3474-4AC6-98E1-3290E96BC75E Q22305491-9E16800D-FC1B-4FF9-B59A-A5236B08E03A Q22305936-8DABD68C-B1EC-4662-A0FB-03E2629534FB Q24193940-656A28B6-BC2A-4CA3-9D24-90B6F8EFD2B9 Q24194770-CDA6AE5D-6018-482D-9BC7-5260E5FCC854 Q24194815-F0A46842-F9DE-4169-AEE7-C5954857DA2C Q24197485-528201D7-9F03-4CDE-8C53-088B68068FE4 Q24200189-485B8AEE-E5A9-4130-9E73-3258EEB30690 Q24200197-42C94F3C-6800-4DF4-8D40-44F3ABC2737A Q24200534-60276C93-A23E-4963-90C4-87C85198D742 Q24201226-867B1CF8-D4E7-45BF-B07E-C5539BE47C22 Q24202464-B2DB9A18-9596-4D05-B196-01D8BB95A560 Q24234215-599C9179-4573-43BC-B028-398ECDFFAEB5 Q24234444-597D9630-C706-4DDA-881A-B9028F38FA0B Q24235606-D8B9D0A3-01A6-48AD-8E27-4A147B1EE0B8 Q24241360-C42198CC-8DD5-4589-BD92-91549911CF62 Q24312182-CACFEF4F-EF82-46E5-8512-3E24BD3B6021 Q24628717-C3B3CAB3-95C1-4036-92E6-9AAD8041144D Q24635330-DED14D38-E6FA-4F22-B5C8-3CEA6F53E95D Q24658465-DB4AAA23-35A3-4EC3-9212-DA5B2CCE36E7 Q26745769-B5A3B047-989D-47CC-91CD-FE7602E19612 Q26746910-FC1B9C2A-2124-45F6-B4FA-E4D2EF6C3343 Q26752471-2E04A8B7-6B03-4DC8-9D0A-A0289781FBE0 Q26768128-58AF2614-7811-4C70-AE53-07503520C463 Q26770817-22DDC753-9EC7-4F77-AFBF-DC4428A76FD3 Q26771458-A1F4FE66-0394-4CCF-B762-42C5509BE05B Q26772324-5F996F9E-C649-46C7-802A-4BCC93F9359C Q26773183-ABCE35FF-B79D-4702-8E9A-5FD1DC34FC75 Q26773289-941449DE-562E-475F-ACC9-C77C8F9D2DAD Q26775815-DCB9F11C-F3AB-40B2-8B5C-E5BD8DF5EE5A Q26776180-2CEFAA5E-B0E3-4CC6-B19E-59D7D00646C3 Q26776408-E39CD9BF-A5BA-4F95-A82B-EAA54080496F Q26781890-C0EF2F02-70E6-49F7-B346-0BD298C7CD38 Q26781993-E4CCAEB2-0D3D-4AAE-8E51-3BB84FA2E1A6 Q26782033-97C74574-3D42-4F74-89B6-91BAFEDC0EEA Q26783056-C7E6C736-8AC4-4BE2-B64B-EBC6BEC33B56

P2860

Diagnosis, management, and treatment of hepatitis C: an update

http://www.wikidata.org/entity/Q29619682

description

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2009

@ast

im April 2009 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: April 2009)

@en

wetenschappelijk artikel (gepubliceerd in 2009-04)

@nl

наукова стаття, опублікована у квітні 2009

@uk

مقالة علمية (نشرت في أبريل 2009)

@ar

name

Diagnosis, management, and treatment of hepatitis C: an update

@ast

Diagnosis, management, and treatment of hepatitis C: an update

@en

type

label

Diagnosis, management, and treatment of hepatitis C: an update

@ast

Diagnosis, management, and treatment of hepatitis C: an update

@en

prefLabel

Diagnosis, management, and treatment of hepatitis C: an update

@ast

Diagnosis, management, and treatment of hepatitis C: an update

@en

P1433

Q29619682-EF71C876-72CC-4AB0-BD3C-4827553CFB22

P1476

Q29619682-CE006057-74E3-430E-8ADD-3F7770547B22

P2093

Q29619682-238A8CE0-A54A-4338-8FB7-609B6B64E1D4

Q29619682-74B9F454-83DA-4B0E-AF03-A34612559A74

Q29619682-9C269287-6041-4161-91C8-039E8F7699AA

Q29619682-F1C6D97E-17C3-47D3-A492-C4794605CBBC

P2860

Q29619682-01F2CC5A-B546-4A30-8BAB-1617AA4706A5

Q29619682-02577349-1520-43F4-BF12-ACDDD1BE8DF6

Q29619682-0404AA86-5B4A-481B-BC66-C865B6236A32

Q29619682-04111439-C6A5-419C-BCA6-57D61FBD77A4

Q29619682-0454FB48-8FF2-41EA-A831-3D9203F5E237

Q29619682-04DF3048-7EDA-46E1-BB31-8E2E7EDC1BE8

Q29619682-05483466-1FDF-4F0A-A80F-7368E50564D0

Q29619682-06E8D7A0-FE5D-4DB7-B9A9-B22D6A097108

Q29619682-09107F46-DBC3-48FF-8F4E-3E94E4F74A99

Q29619682-0A649F45-77D6-441A-AE09-02EB105AEF70

P304

Q29619682-0440D4AD-405D-4BFB-833C-CDA96846A08F

P31

Q29619682-58EE3567-AF63-4A87-ABCE-D431A618C5ED

P3181

Q29619682-343F9615-7690-4EF6-BA42-EB3D03F7E5CD

P356

Q29619682-C770055B-D65D-468D-A164-E1FFF9339425

P407

Q29619682-5C98948F-2298-46BB-9388-206AC9525E35

P433

Q29619682-51613C50-0EE8-43BA-BCDB-B0E6C365C27B

P478

Q29619682-88E3D88D-56A2-41AB-B1B7-76D040B7B1DA

P577

Q29619682-DF7B0DDF-14EB-4DC2-BDAF-3181D74009ED

P5875

Q29619682-48D4EEAD-5A89-4F01-B8C6-CA2B6679BDC1

P698

Q29619682-173A21E4-8E39-4DEB-8324-6756C7A46461

P921

Q29619682-465375c8-3570-4491-bbe0-394469c22662

Q29619682-f155e86f-4e07-3320-3ebc-447b1d3db600

P3181

P356

P1433

P1476

Diagnosis, management, and treatment of hepatitis C: an update

@en

P2093

Ghany MG

http://www.w3.org/2001/XMLSchema#string

Seeff LB

http://www.w3.org/2001/XMLSchema#string

Strader DB

http://www.w3.org/2001/XMLSchema#string

Thomas DL

http://www.w3.org/2001/XMLSchema#string

P2860

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

An Inventory for Measuring Depression

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

Steatosis affects chronic hepatitis C progression in a genotype specific way

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Hepatitis C virus infection acquired in childhood

Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected Patients

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

P304

1335-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

363154

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.22759

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24243300

http://www.w3.org/2001/XMLSchema#string

P698

19330875

http://www.w3.org/2001/XMLSchema#string

P921